Gene | Phenotype | SNP | Genotype | Negative N (%) | Positive N (%) | OR (95% CI) | Nominal P Value |
---|---|---|---|---|---|---|---|
PHF11 | SPTa | rs2247119 | TT | 167 (35.9) | 161 (30.8) | 1 | Â |
 |  |  | CT | 213 (45.8) | 263 (50.3) | 1.27 (0.95-1.67) | 0.10 |
 |  |  | CC | 85 (18.3) | 99 (18.9) | 1.14 (0.79-1.65) | 0.48 |
 |  |  |  | Dominant Model |  | 1.23 (0.94-1.61) | 0.13 |
 | SPT + Asthma b | rs2247119 | TT | 138 (35.8) | 109 (32.2) | 1 |  |
 |  |  | CT | 179 (46.5) | 169 (49.9) | 1.18 (0.84-1.65) | 0.35 |
 |  |  | CC | 68 (17.7) | 61 (18.0) | 1.08 (0.69-1.67) | 0.74 |
 |  |  |  | Dominant Model |  | 1.15 (0.84-1.58) | 0.39 |
DPP10 | MTCH Challengec | rs10192393 | TT | 404 (92.0) | 393 (86.2) | 1 | Â |
 |  |  | CT | 34 (7.7) | 62 (13.6) | 1.91 (1.21-3.03) | 0.0059 |
 |  |  | CC | 1 (0.2) | 1 (0.2) | 1.46 (0.09-23.56) | 0.79 |
 |  |  |  | Dominant Model |  | 1.90 (1.20-3.00) | 0.0059 |
 | MTCH Challenge + Asthma d | rs10192393 | TT | 360 (92.3) | 284 (85.8) | 1 |  |
 |  |  | CT | 29 (7.4) | 46 (13.9) | 2.04 (1.22-3.42) | 0.0070 |
 |  |  | CC | 1 (0.3) | 1 (0.3) | 1.66 (0.10-27.13) | 0.72 |
 |  |  |  | Dominant Model |  | 2.03 (1.22-3.37) | 0.0067 |
HLA-G | MTCH Challenge | rs1736935 | CC | 150 (32.6) | 191 (37.5) | 1 | Â |
 |  |  | CT | 227 (49.3) | 241 (47.3) | 0.82 (0.61-1.09) | 0.17 |
 |  |  | TT | 83 (18.0) | 77 (15.1) | 0.73 (0.49-1.07) | 0.10 |
 |  |  |  | Additive Model |  | 0.85 (0.70-1.02) | 0.079 |
 | MTCH Challenge + Asthma | rs1736935 | CC | 136 (33.9) | 152 (39.3) | 1 |  |
 |  |  | CT | 192 (47.9) | 181 (46.8) | 0.84 (0.61-1.15) | 0.27 |
 |  |  | TT | 73 (18.2) | 54 (14.0) | 0.64 (0.41-0.99) | 0.044 |
 |  |  |  | Additive Model |  | 0.81 (0.65-0.99) | 0.043 |